| 1. |
Gioffredi A, Maritati F, Oliva E, Buzio C. Eosinophilic granulomatosis with polyangiitis: an overview. Front Immunol, 2014, (5): 549.
|
| 2. |
Jennette JC, Falk RJ, Andrassy K, et al. Nomenclature of systemic vasculitides. Proposal of an international consensus conference. Arthritis Rheum, 1994, 37(2): 187-192.
|
| 3. |
Jennette JC, Falk RJ, Bacon PA, et al. 2012 revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides. Arthritis Rheum, 2013, 65(1): 1-11.
|
| 4. |
Woolnough K, Wardlaw AJ. Eosinophilia in Pulmonary Disorders. Immunol Allergy Clin North Am, 2015, 35(3): 477-492.
|
| 5. |
Mouthon L, Dunogue B, Guillevin L. Diagnosis and classification of eosinophilic granulomatosis with polyangiitis (formerly named Churg-Strauss syndrome). J Autoimmun, 2014, 48-49: 99-103.
|
| 6. |
Mahr A, Moosig F, Neumann T, et al. Eosinophilic granulomatosis with polyangiitis (Churg-Strauss): evolutions in classification, etiopathogenesis, assessment and management. Curr Opin Rheumatol, 2014, 26(1): 16-23.
|
| 7. |
Santos YA, Silva BR, Lira PN, et al. Eosinophilic granulomatosis with polyangiitis (formerly known as Churg-Strauss syndrome) as a differential diagnosis of hypereosinophilic syndromes. Respir Med Case Rep, 2017, 21: 1-6.
|
| 8. |
Parent ME, Larue S, Ellezam B. Eosinophilic granulomatosis with polyangiitis (Churg-Strauss syndrome) presenting as diffuse myositis. BMC Musculoskelet Disord, 2014, 15: 388.
|
| 9. |
Masi AT, Hunder GG, Lie JT, et al. The American College of Rheumatology 1990 criteria for the classification of Churg-Strauss syndrome (allergic granulomatosis and angiitis). Arthritis Rheum, 1990, 33(8): 1094-1100.
|
| 10. |
Comarmond C, Pagnoux C, Khellaf M, et al. Eosinophilic granulomatosis with polyangiitis (Churg-Strauss): clinical characteristics and long-term follow up of the 383 patients enrolled in the French Vasculitis Study Group cohort. Arthritis Rheum, 2013, 65(1): 270-281.
|
| 11. |
Guillevin L, Pagnoux C, Seror R, et al. The five-factor score revisited: assessment of prognoses of systemic necrotizing vas-culitides based on the French Vasculitis Study Group(FVSG) cohort. Medicine (Baltimore), 2011, 90(1): 19-27.
|
| 12. |
Lefèvre G, Ackermann F, Kahn JE. Hypereosinophilia with asthma and systemic (non-vasculitic) manifestations: Eosinophilic granulomatosis with polyangiitis or hypereosinophilic syndrome?. Autoimmun Rev, 2017, 16(2): 208-209.
|
| 13. |
Noh HR, Magpantay GG. Hypereosinophilic syndrome. Allergy Asthma Proc, 2017, 38(1): 78-81.
|
| 14. |
Tracy MC, Okorie CUA, Foley EA, et al. Allergic bronchopulmonary aspergillosis. J Fungi (Basel), 2016, 2(2): E17.
|
| 15. |
Agarwal R, Sehgal IS, Dhooria S, et al. Developments in the diagnosis and treatment of allergic bronchopulmonary aspergillosis. Expert Rev Respir Med, 2016, 10(12): 1317-1334.
|
| 16. |
Greenberger PA, Bush RK, Demain JG, et al. Allergic bronchopulmonary aspergillosis. J Allergy Clin Immunol Pract, 2014, 2(6): 703-708.
|
| 17. |
Opriţă R, Opriţă B, Berceanu D, et al. Overview of IgG4-related disease. J Med Life, 2017, 10(4): 203-207.
|
| 18. |
Şen N, Aydın Tufan M, Yıldız R, et al. Granulomatous polyangiitis (Wegener granulomatosis): clinical findings and results of long-term follow-up. Tuberk Toraks, 2016, 64(3): 223-229.
|
| 19. |
Pagnoux C, Groh M. Optimal therapy and prospects for new medicines in eosinophilic granulomatosis with polyangiitis (Churg-Strauss syndrome). Expert Rev Clin Immunol, 2016, 12(10): 1059-1067.
|
1/5
WeChat